NASDAQ:ESPR
Esperion Therapeutics Stock News
$2.36
-0.230 (-8.88%)
At Close: May 17, 2024
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
10:00pm, Friday, 15'th May 2020
Esperion (ESPR) today announced that, on May 15, 2020, the Compensation Committee of Esperion’s Board of Directors granted 88,902 restricted stock units (RSUs) to 194 new colleagues under Esperion�
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 56'5(c)(4)
12:00am, Friday, 15'th May 2020Esperion Therapeutics' Festive Q1 2020 Earnings Call
10:28am, Wednesday, 13'th May 2020
Esperion is a true specialist focused on its niche mission of lipid management. The company's Q1 2020 earnings call reveled in product approvals and launches fo
Analysts Are Upgrading Esperion Therapeutics, Inc. (NASDAQ:ESPR) After Its Latest Results
06:49pm, Friday, 08'th May 2020
Esperion Therapeutics, Inc. (NASDAQ:ESPR) investors will be delighted, with the company turning in some strong numbers...
Eye-Catching Quarterly Results From a Trio of Companies
12:38pm, Friday, 08'th May 2020
The first-quarter reports from Camping World, Esperion Therapeutics and BioDelivery Sciences were impressive amid coronavirus disruption.
Jefferies Maintains Buy on Esperion Therapeutics, Lowers Price Target to $70
05:32pm, Thursday, 07'th May 2020Esperion (ESPR) Q1 Earnings and Revenues Beat Estimates
03:47pm, Thursday, 07'th May 2020
Esperion Therapeutics (ESPR) reports encouraging first-quarter results. The company records product revenues for the first time during the quarter.
U.S. RESEARCH ROUNDUP-Ashland Global, Lyft, Solaredge Technologies
03:19pm, Thursday, 07'th May 2020
Wall Street securities analysts on Thursday revised their ratings and
price targets on several U.S.-listed companies, including Ashland Global Holdings, Lyft and
Solaredge Technologies.
HIGH
Esperion Therapeutics Inc (ESPR) Q1 2020 Earnings Call Transcript
01:01pm, Thursday, 07'th May 2020
ESPR earnings call for the period ending March 31, 2020.
Esperion to Participate in Fireside Chat at the BofA Securities 2020 Healthcare Conference
12:00pm, Thursday, 07'th May 2020
Esperion (ESPR), today announced that president and chief executive officer, Tim M. Mayleben, will participate in an analyst-led fireside chat at the BofA Securities 2020 Healthcare Conference on Tues
Edited Transcript of ESPR earnings conference call or presentation 6-May-20 8:30pm GMT
11:29am, Thursday, 07'th May 2020
Q1 2020 Esperion Therapeutics Inc Earnings Call
Esperion Therapeutics' (ESPR) CEO Tim Mayleben on Q1 2020 Results - Earnings Call Transcript
04:08am, Thursday, 07'th May 2020
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q1 2020 Earnings Conference Call May 6, 2020 4:30 PM ET Company Participants Alex Schwartz – Head-Investor Relations T
Esperion Therapeutics (ESPR) Reports Q1 Loss, Tops Revenue Estimates
10:55pm, Wednesday, 06'th May 2020
Esperion Therapeutics (ESPR) delivered earnings and revenue surprises of 9.55% and 91.67%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
